Sensitivity of periodontal pathogens to the bactericidal activity of synthetic protegrins, antibiotic peptides derived from porcine leukocytes

Journal of Dental Research

Volumn 76, Issue 8, 1997, Pages 1453-1459

  Miyasaki, K T ^a   Iofel, R ^a   Lehrer, R I ^b  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bactericidal antibiotic peptides; Oral; Periodontal; Protegrin

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; PROTEGRIN PG 1; PROTEGRIN PG 2; PROTEGRIN PG 3; PROTEGRIN PG 5; PROTEGRIN PG-1; PROTEGRIN PG-2; PROTEGRIN PG-3; PROTEGRIN PG-5; PROTEIN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL; ARTICLE; BACTERIAL COUNT; CAPNOCYTOPHAGA; CHEMISTRY; DRUG EFFECT; FUNCTIONS OF THE HEMIC, LYMPHATIC AND RETICULOENDOTHELIAL SYSTEMS; HUMAN; LEUKOCYTE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PERIODONTAL DISEASE; SWINE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PHYSIOLOGY; CAPNOCYTOPHAGA; COLONY COUNT, MICROBIAL; HUMANS; LEUKOCYTES; MICROBIAL SENSITIVITY TESTS; PERIODONTAL DISEASES; PROTEINS; SWINE;

EID: 0031203411     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/00220345970760080701     Document Type: Article

References (23)

1. Abbott BH, Caffesse RG (1977). Crevicular fluid: origin, composition, methods of collection, and clinical significance. J West Soc Periodontol 25:164-178.
2. ASM Task Force on Antibiotic Resistance (1995). Report of the ASM Task Force on Antibiotic Resistance. Washington, DC: American Society for Microbiology.
3. Fahrner RL, Dieckmann T, Harwig SSL, Lehrer RI, Eisenberg D, Feigon J (1996). Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol 3:543-550.
4. Forlenza SW, Newman MG, Lipsey AI, Siegel SE, Blachman U (1980). Capnocytophaga sepsis: newly recognised clinical entity in granulocytopenic patients. Lancet i:567-568.
5. Gabay JE (1994). Ubiquitous natural antibiotics. Science 264:373-374.
6. Harwig SS, Swiderek KM, Lee TD, Lehrer RI (1995). Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J Eur Peptide Sci 3:207-215.
7. Hill CP, Yee J, Selsted ME, Eisenberg D (1991). Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251:1481-1485.
8. Kalmar JR, Arnold RR, van Dyke TE (1987). Direct interaction of Actinobacillus actinomycetemcomitans with normal and defective (LJP) neutrophils. J Periodont Res 22:179-181.
9. Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, et al. (1993). Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 327:231-236.
10. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME (1989). Interaction of human defensins with Escherichia coli: mechanism of bactericidal activity. J Clin Invest 84:553-561.
11. Mandel ID, Wotman S (1976). The salivary secretions in health and disease. Oral Sci Rev 8:25-47.
12. Masuda K, Ohta M, Ito M, Ohsuka S, Kaneda T, Kato N (1994). Bactericidal action of tachyplesin I against oral streptococci. Oral Microbiol Immunol 9:77-80.
13. Miyasaki KT, Bodeau AL (1991). In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J Clin Invest 87:1585-1593.
14. Miyasaki KT, Bodeau AL, Ganz T, Selsted ME, Lehrer RI (1990). In vitro sensitivity of oral, Gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun 58:3934-3940.
15. Miyasaki KT, Bodeau AL, Pohl J, Shafer WM (1993). Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena. Antimicrob Agents Chemother 37:2710-2715.
16. Page RC (1992). Host response tests for diagnosing periodontal diseases. J Periodontol 63:356-366.
17. Qu XD, Harwig SS, Oren AM, Shafer WM, Lehrer RI (1996). Susceptibility of Neisseria gonorrhoeae to protegrins. Infect Immun 64:1240-1245.
18. Ritonja A, Kopitar M, Jerala R, Turk V (1989). Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett 255:211-214.
19. Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, et al. (1995). Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem Pharm Bull 43:853-858.
20. Verbanac D, Zanetti M, Romeo D (1993). Chemotactic and protease-inhibiting activities of antibiotic peptide precursors. FEBS Lett 317:255-258.
21. Wade D, Boman A, Wåhlin B, Drain CM, Andreu D, Boman HG, et al. (1990). All-D amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci USA 87:4761-4765.
22. Zhao C, Liu L, Lehrer RI (1994). Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett 346:285-288.
23. Zhao C, Ganz T, Lehrer RI (1995). The structure of porcine protegrin genes. FEBS Lett 368:197-202.